The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 21, 2020

Filed:

Mar. 20, 2017
Applicant:

Glaxosmithkline Intellectual Property Development Limited, Brentford, Middlesex, GB;

Inventors:

Lluis Ballell Pages, Tres Cantos, ES;

David Barros Aguirre, Tres Cantos, ES;

Robert H. Bates, Tres Cantos, ES;

Julia Castro Pichel, Tres Cantos, ES;

Jorge Esquivias Provencio, Tres Cantos, ES;

Kevin Pethe, Singapore, SG;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/513 (2006.01); C07D 401/06 (2006.01); A61P 31/06 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/513 (2013.01); A61K 45/06 (2013.01); A61P 31/06 (2018.01); C07D 401/06 (2013.01);
Abstract

The present invention relates to the use in therapy of 6-((4-(2,3-dimethylphenoxy)piperidin-1-yl)methyl)pyrimidine-2,4(1H,3H)-dione or a pharmaceutically acceptable salt thereof, to pharmaceutically acceptable salts of 6-((4-(2,3-dimethylphenoxy)piperidin-1-yl)methyl)pyrimidine-2,4(1H,3H)-dione and to pharmaceutical formulations comprising 6-((4-(2,3-dimethylphenoxy)piperidin-1-yl)methyl)pyrimidine-2,4(1H,3H)-dione or a pharmaceutically acceptable salt thereof.


Find Patent Forward Citations

Loading…